Yogameenakshi Haribabu

5PUBLICATIONS
10CO-AUTHORS
Radiation and matterMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 15, 2026
Correction: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333.

|Apr 27, 2026
Correction: Alobaidi et al. Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth. Cells 2025, 14, 248.

|Feb 25, 2025
Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth.

Ryyan Alobaidi, Nusrat Islam, Toni Olkey

|May 10, 2024
CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.

Cynthia M Simbulan-Rosenthal, Nusrat Islam, Yogameenakshi Haribabu

|Feb 26, 2022
Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells.

Cynthia M Simbulan-Rosenthal, Yogameenakshi Haribabu, Sahar Vakili

Pageof 1

Frequent Collaborators

5 joint publications

Cynthia M Simbulan-Rosenthal

5 joint publications

Peter Sykora

5 joint publications

Dean S Rosenthal

3 joint publications

Ryyan Alobaidi